Rhodiola rosea, a plant-root extract sold as a dietary supplement to build resilience to stress, shows modest, short-lived effects. The clearest is a small endurance gain from a dose taken shortly before exercise; evidence for stress-related fatigue and mood is mixed. Lifespan claims rest on worms, flies and mice. Main concerns are mild side effects, slowed liver breakdown of some medicines and uneven product quality. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Blood pressure (seated, home) | No established target; track change from own baseline | Safety check: lowering with blood-pressure drugs |
| Fasting glucose | 70–99 mg/dL (standard reference range) | Safety check: low blood sugar with glucose-lowering drugs |
| INR (international normalized ratio) | 0.8–1.2 without anticoagulants (blood thinners; standard reference range); prescriber-set target on warfarin | Safety check: CYP2C9 inhibition may raise warfarin effect |
Cadence: Blood pressure rechecks at 1 week and 4 weeks, then every 3 months during continued use; fasting glucose rechecks on the same schedule for users of glucose-lowering medicine; INR recheck 1–2 weeks after starting for warfarin users; repeat questionnaires at 4 and 12 weeks